UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Colonic mucosal associated invariant T cells in Crohn’s disease have a diverse and non-public T cell receptor beta chain repertoire

PloS one, 2023-11, Vol.18 (11), p.e0285918-e0285918

2023

Volltextzugriff (PDF)

Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease

PloS one, 2015-08, Vol.10 (8), p.e0136485-e0136485

2015

Volltextzugriff (PDF)

Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease

Digestive diseases and sciences, 2018-09, Vol.63 (9), p.2419-2429

2018

Volltextzugriff (PDF)

Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease

World journal of gastroenterology : WJG, 2017-05, Vol.23 (18), p.3240-3251

2017

Volltextzugriff (PDF)

Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T Cells

Inflammatory bowel diseases, 2024-05, Vol.30 (5), p.704-717

2024

Volltextzugriff (PDF)

Janus Kinase Inhibitors Differentially Inhibit Specific Cytokine Signals in the Mesenteric Lymph Node Cells of Inflammatory Bowel Disease Patients

Journal of Crohn's and colitis, 2024-04, Vol.18 (4), p.628-637

2024

Volltextzugriff (PDF)

IL-1RL2 and its ligands contribute to the cytokine network in psoriasis

The Journal of immunology (1950), 2010-10, Vol.185 (7), p.4354-4362

2010

Volltextzugriff (PDF)

Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotype

Clinical immunology (Orlando, Fla.), 2018-08, Vol.193, p.24-32

2018

Volltextzugriff (PDF)

T Cell Repertoire Homogeneity and Blood-Gut Overlap in Patients With Inflammatory Bowel Disease

Cellular and molecular gastroenterology and hepatology, 2024, Vol.17 (1), p.119-130

2024

Volltextzugriff (PDF)

MAdCAM-1 Costimulates T Cells through Integrin α4β7 to Cause Gene Expression Events Resembling Costimulation through CD28

ImmunoHorizons, 2022-03, Vol.6 (3), p.211-223

2022

Volltextzugriff (PDF)

1052 USTEKINUMAB DECREASES CIRCULATING TH1, TH17, AND MAIT CELLS IN CROHN'S DISEASE

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-229-S-230

2023

Volltextzugriff (PDF)

Escherichiacoli–Specific CD4+ T Cells Have Public T-Cell Receptors and Low Interleukin 10 Production in Crohn’s Disease

Cellular and molecular gastroenterology and hepatology, 2020, Vol.10 (3), p.507-526

2020

Volltextzugriff (PDF)

Tu1182 COLON EPITHELIAL CELLS FROM HEALTHY CONTROLS BUT NOT CROHN'S PATIENTS PROMOTE T CELL FOXP3 AND CTLA4 EXPRESSION

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1272-S-1272

2024

Volltextzugriff (PDF)

Helicobacter bilis Infection Accelerates and H. hepaticus Infection Delays the Development of Colitis in Multiple Drug Resistance-Deficient ( mdr1a−/−) Mice

The American journal of pathology, 2002-02, Vol.160 (2), p.739-751

2002

Volltextzugriff (PDF)

THE EFFECT OF VEDOLIZUMAB ON CD8 T CELL REPERTOIRE HOMOGENEITY AND BLOOD-GUT TRAFFICKING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Gastroenterology (New York, N.Y. 1943), 2023-04, Vol.164 (4), p.S103-S103

2023

Volltextzugriff (PDF)

Mo1874 BLOOD T CELL FREQUENCIES PREDICT AND CORRELATE WITH RESPONSE TO USTEKINUMAB IN INFLAMMATORY BOWEL DISEASE

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-958-S-958

2020

Volltextzugriff (PDF)

Mo1849 SUCCESSFUL ANTI-INTEGRIN ALPHA4/BETA7 THERAPY REDUCES INTRACOLONIC DENDRITIC CELLS, NOT EFFECTOR T CELLS IN INFLAMMATORY BOWEL DISEASE

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1142-S-1142

2024

Volltextzugriff (PDF)

THE EFFECT OF VEDOLIZUMAB ON CD8 T CELL REPERTOIRE HOMOGENEITY AND BLOOD-GUT TRAFFICKING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Inflammatory bowel diseases, 2023-01, Vol.29 (Supplement_1), p.S80-S81

2023

Volltextzugriff (PDF)

Conserved IFN Signature between Adult and Pediatric Eosinophilic Esophagitis

The Journal of immunology (1950), 2021-03, Vol.206 (6), p.1361-1371

2021

Volltextzugriff (PDF)

Mo1122 – Gene Expression Profiling and Flow Cytometry of Esophageal Biopsies Demonstrates Diverse Immune Infiltrate in Eosinophilic Esophagitis

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-713-S-713

2019

Volltextzugriff (PDF)

Conserved interferon signature between adult and pediatric eosinophilic esophagitis

The Journal of immunology (1950), 2021-02, Vol.206 (6), p.1361-1371

2021

Volltextzugriff (PDF)

Tu1329 IBD Patients Taking Thiopurine Medications Have Fewer B and NK Cells

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-861-S-861

2015

Volltextzugriff (PDF)

Tu1295 Effect of Vedolizumab on Circulating Lymphocyte Subsets in IBD

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-851-S-851

2015

Volltextzugriff (PDF)

Tu1889 - Circulating E. Coli OmpC Peptide-Specific T Cells Isolated by MHC-Ii Tetramers Show a Gut-Tropic Phenotype and Increased CD226 Expression in Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S999-S999

2017

Volltextzugriff (PDF)

137 - Integrin α4β7 Expression Preceding and Saturation During Vedolizumab Therapy Correlate with Treatment Response in Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S39-S39

2017

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Colonic mucosal associated invariant T cells in Crohn’s disease have a diverse and non-public T cell receptor beta chain repertoire

Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease

Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease

Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease

Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T Cells

Janus Kinase Inhibitors Differentially Inhibit Specific Cytokine Signals in the Mesenteric Lymph Node Cells of Inflammatory Bowel Disease Patients

IL-1RL2 and its ligands contribute to the cytokine network in psoriasis

Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotype

T Cell Repertoire Homogeneity and Blood-Gut Overlap in Patients With Inflammatory Bowel Disease

MAdCAM-1 Costimulates T Cells through Integrin α4β7 to Cause Gene Expression Events Resembling Costimulation through CD28

1052 USTEKINUMAB DECREASES CIRCULATING TH1, TH17, AND MAIT CELLS IN CROHN'S DISEASE

Escherichiacoli–Specific CD4+ T Cells Have Public T-Cell Receptors and Low Interleukin 10 Production in Crohn’s Disease

Tu1182 COLON EPITHELIAL CELLS FROM HEALTHY CONTROLS BUT NOT CROHN'S PATIENTS PROMOTE T CELL FOXP3 AND CTLA4 EXPRESSION

Helicobacter bilis Infection Accelerates and H. hepaticus Infection Delays the Development of Colitis in Multiple Drug Resistance-Deficient ( mdr1a−/−) Mice

THE EFFECT OF VEDOLIZUMAB ON CD8 T CELL REPERTOIRE HOMOGENEITY AND BLOOD-GUT TRAFFICKING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Mo1874 BLOOD T CELL FREQUENCIES PREDICT AND CORRELATE WITH RESPONSE TO USTEKINUMAB IN INFLAMMATORY BOWEL DISEASE

Mo1849 SUCCESSFUL ANTI-INTEGRIN ALPHA4/BETA7 THERAPY REDUCES INTRACOLONIC DENDRITIC CELLS, NOT EFFECTOR T CELLS IN INFLAMMATORY BOWEL DISEASE

THE EFFECT OF VEDOLIZUMAB ON CD8 T CELL REPERTOIRE HOMOGENEITY AND BLOOD-GUT TRAFFICKING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Conserved IFN Signature between Adult and Pediatric Eosinophilic Esophagitis

Mo1122 – Gene Expression Profiling and Flow Cytometry of Esophageal Biopsies Demonstrates Diverse Immune Infiltrate in Eosinophilic Esophagitis

Conserved interferon signature between adult and pediatric eosinophilic esophagitis

Tu1329 IBD Patients Taking Thiopurine Medications Have Fewer B and NK Cells

Tu1295 Effect of Vedolizumab on Circulating Lymphocyte Subsets in IBD

Tu1889 - Circulating E. Coli OmpC Peptide-Specific T Cells Isolated by MHC-Ii Tetramers Show a Gut-Tropic Phenotype and Increased CD226 Expression in Crohn's Disease

137 - Integrin α4β7 Expression Preceding and Saturation During Vedolizumab Therapy Correlate with Treatment Response in Inflammatory Bowel Disease

Suchergebnisse filtern